Personalized medicine and genetic malpractice : Genetics in Medicine : Nature Publishing Group

Personalized medicine and genetic malpractice : Genetics in Medicine : Nature Publishing Group

Article preview View full access options

Genetics in Medicine | Commentary

• Print
• Email
• Share/bookmark

Personalized medicine and genetic malpractice

• Gary E. Marchant PhD, JD
• & Rachel A. Lindor JD

• Affiliations
• Corresponding author

Genetics in Medicine

(2013)

doi:10.1038/gim.2013.142

Received

30 July 2013

Accepted

07 August 2013

Published online

26 September 2013

Article tools

• Citation
• Reprints
• Rights & permissions

Angelina Jolie’s recent revelation that she had prophylactic surgery to reduce her breast cancer risk after BRCA genetic testing has increased public interest in preventive genetic testing. This so-called “Angelina effect” exemplifies a growing consumer interest and medical uptake of genetic testing in response to the increased availability and utility…

Read the full article

• Subscribe to Genetics in Medicine for full access: €763

  Subscribe

• ReadCube Access*

  

  *printing and sharing restrictions apply

• Purchase article full text and PDF: €16

  Buy now

Already a subscriber? Log in now or Register for online access.

Members of the American College of Medical Genetics and Genomics receive access to Genetics in Medicine as part of their membership. Access is available through the American College of Medical Genetics and Genomics web site.

Additional access options:

• Use a document delivery service
• Login via Athens
• Purchase a site license
• Institutional access

References

• References•
• Author information

1. Downs v. Trias, 49 A.3d 180 (Conn. 2012).
2. Levy v. Legacy Health System, 2012 WL 1646980 (Or.Cir. 2012).
3. Scholz v. Kaiser Foundation Hospital, RG12614636, Alameda Sup. Ct. (filed Jan. 30, 2012).
4. Marchant GE, Lindor RA, Campos-Outcalt DE. Physician liability: the next big thing for personalized medicine? Personal Med 2012;8:457–467.
   • Article
5. De Ville K. Medical malpractice in twentieth century United States. The interaction of technology, law and culture. Int J Technol Assess Health Care 1998;14:197–211.
   • PubMed
   • Article
6. Grady MF. Why are people negligent? technology, nondurable precautions, and the medical malpractice explosion. Northwest U Law Rev 1988;82:293–334.
7. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200–1205.
   • CAS
   • ISI
   • PubMed
   • Article
8. Stanek EJ, Sanders CL, Taber KA, et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther 2012;91:450–458.
   • CAS
   • PubMed
   • Article
9. Haga SB, Burke W, Agans R. Primary-care physicians’ access to genetic specialists: an impediment to the routine use of genomic medicine? Genet Med 2013;15:513–514.
   • PubMed
   • Article
10. Mello MM. Of swords and shields: the use of clinical practice guidelines in medical malpractice litigation. U Penn Law Rev 2000;149:645–710.
    • Article

Download references

Author information

• References•
• Author information•

Affiliations

1. Center for Law, Science, Innovation, Arizona State University, Tempe, Arizona, USA

   • Gary E. Marchant

2. Mayo Clinic College of Medicine, Rochester, Minnesota, USA

   • Rachel A. Lindor

Corresponding author

Correspondence to:

• Gary E. Marchant

Additional data

Most read

1. “I prefer a child with …”: designer babies, another controversial patent in the arena of direct-to-consumer genomics

   Genetics in Medicine 03 October 2013

2. Managing incidental findings and research results in genomic research involving biobanks and archived data sets

   Genetics in Medicine 05 April 2012

3. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

   Genetics in Medicine 20 June 2013